CS-514 suppresses plasma triglyceride in hypertriglyceridemic subjects without modifying a lipoprotein structural model.
D005260:Female; D006538:Heptanoic Acids / Q000494:pharmacology*; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood*; D008074:Lipoproteins; D008297:Male; D008875:Middle Aged; D008961:Models, Structural; D009281:Naphthalenes / Q000494:pharmacology*; D017035:Pravastatin; D014280:Triglycerides / Q000097:blood*
D006538:Heptanoic Acids; D008074:Lipoproteins; D009281:Naphthalenes; D014280:Triglycerides; D017035:Pravastatin